Rheumatoid arthritis patients' oral health and disease activity.


Journal

International journal of rheumatic diseases
ISSN: 1756-185X
Titre abrégé: Int J Rheum Dis
Pays: England
ID NLM: 101474930

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 05 09 2018
revised: 25 02 2019
accepted: 01 04 2019
pubmed: 8 5 2019
medline: 30 1 2020
entrez: 8 5 2019
Statut: ppublish

Résumé

Rheumatoid arthritis (RA) and periodontal diseases (PD) are common chronic, inflammatory, destructive and progressive diseases that may have similar pathophysiological mechanisms and risk factors. RA affects more than 1.5% of the world's population, with a higher percentage of females than males. PD is present in around 20% of the population and has multifactorial etiology. The purpose of this study is to describe patients' self-reported oral health and the association with RA disease activity. Three hundred patients under treatment for RA from the Division of Rheumatology, Clinical Medicine, North Jutland Region Hospital, Hjørring, Denmark and were eligible for the study. Questionnaires were emailed to the patients and 164 completed answers were received. The mean age of the group of 164 patients (61% female) was 65 ± 11 years. The average value of Disease Activity Score of 28 joints was 2.31 ± 0.83. Only 12% of responders were active smokers. Patients estimated their status of their teeth and gingiva respectively as poor in 13% and 11% of cases, good, in 46% and 49%, and excellent, both as 40%. Spontaneous and/or provoked gingival bleeding were experienced by 15% and 49% of patients. Only 14% of patients declared feelings of loose or movable teeth and 10% declared difficulties in biting or chewing. The status of oral cavity reported by Danish patients indicates a significant proportion with symptoms of gingival/periodontal disease, which may negatively influence RA activity and disease management. Cooperation between rheumatologists and dentists is important in oral health management in periodontal inflammation.

Identifiants

pubmed: 31062938
doi: 10.1111/1756-185X.13590
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1538-1543

Informations de copyright

© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Auteurs

Małgorzata Radwan-Oczko (M)

Department and Division of Oral Pathology, Wrocław Medical University, Wrocław, Poland.

Irena Duś-Ilnicka (I)

Department and Division of Oral Pathology, Wrocław Medical University, Wrocław, Poland.

Pamela Richards (P)

Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Anna Marie Thomsen (AM)

Rheumatology Department, Clinic of Medicine, North Denmark Regional Hospital, Hjoerring, Denmark.

Claus Rasmussen (C)

Rheumatology Department, Clinic of Medicine, North Denmark Regional Hospital, Hjoerring, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH